๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shenyang
Clinical trial register · China

Clinical Trials in Shenyang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shenyang 21 Fuzhou 4 Shenzhen 2 Dalian 2 Cangzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Shenyang21 Fuzhou4 Shenzhen2 Dalian2 Cangzhou1
All 36 locations
Target enrolment
to

Trials with a site in Shenyang

21 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus
NCT07483359Hepatocellular Carcinoma (HCC), Portal Vein Tumor Thrombus
First Hospital of China Medical University
Phase 2
38
Shenyang
2026-05-20
Active, closed
LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia
NCT07350486Hypertension, Diabetes, Dyslipidemia
First Hospital of China Medical University
Not applicable
6,800
Cangzhou, Suzhou, Panjin, Shenyang, Jinzhou, Tianjin
2026-05-14
Recruiting
First-in-Human Study of the Radioligand 68Ga- DOTA-EphA2
NCT07593209Malignant Tumor
First Hospital of China Medical University
Observational
30
Shenyang
2026-05-01
Recruiting
Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts
NCT07534865Warts
First Hospital of China Medical University
Not applicable
210
Shenyang
2026-05-01
Recruiting
Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis
NCT07503652Palmoplantar Pustulosis (PPP)
First Hospital of China Medical University
Phase 4
10
Shenyang
2026-03
Not yet open
Digital Technology Combined With Blood Marker Screening and Diagnosis for Community Populations Based on Classification Theory: an Integrated Study
NCT07286812Alzheimer Disease
First Hospital of China Medical University
Observational
1,000
Shenyang
2025-12-25
Recruiting
Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts
NCT07565350Refactory Warts
First Hospital of China Medical University
Not applicable
80
Shenyang
2025-10-01
Recruiting
Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
NCT06696417Moderate to Severe Plaque Psoriasis
First Hospital of China Medical University
Observational
1,516
Shenyang
2025-02-17
Recruiting
The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation and Recurrent Events Evaluation
NCT07085650Atrial Fibrillation (AF), Mitral Regurgitation, Tricuspid Regurgitation
First Hospital of China Medical University
Observational
2,000
Shenyang
2024-12-30
By invitation
Local Hyperthermia for the Treatment of Cervical Persistent High-risk Infection
NCT07059819Cervical Intraepithelial Neoplasia (CIN), Human Papillovirus
First Hospital of China Medical University
Not applicable
400
Shenyang
2024-11-02
Recruiting
HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC
NCT06632093BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Hepatic Arterial Infusion Chemotherapy, Lenvatinib
First Hospital of China Medical University
Observational
84
Shenyang
2024-09-16
Active, closed
HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC
NCT06632106Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitor, Immune Checkpoint Inhibitors, Hepatocellular Carcinoma (HCC)
First Hospital of China Medical University
Observational
97
Shenyang
2024-08-16
Recruiting
Multicenter Real-World Study of Hyperthermia in Warts of Special Population
NCT06827938Warts
First Hospital of China Medical University
Not applicable
400
Shenyang
2024-07-10
Active, closed
Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors
NCT07059832Cancer
First Hospital of China Medical University
Phase 1/2
30
Shenyang
2024-04-01
Recruiting
Antifungal Agents and Infrared Thermotherapy Alone or in Combination in the Treatment of Sporotrichosis
NCT06300138Sporotrichosis
First Hospital of China Medical University
Not applicable
150
Shenyang
2024-03-15
Recruiting
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
NCT06282796Breast Cancer
First Hospital of China Medical University
Observational
600
Fuzhou, Dalian, Shenyang, Chengdu
2024-01-01
Recruiting
Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer
NCT06637215Colorectal Carcinoma, Day Surgery
First Hospital of China Medical University
Not applicable
352
Shenyang
2023-11-01
Recruiting
Nutritional Intervention for Patients With Multiple Cancer Types
NCT06059560Cancer
First Hospital of China Medical University
Not applicable
1,000
Shenyang
2023-10-01
Recruiting
Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts
NCT06812065Warts
First Hospital of China Medical University
Not applicable
300
Shenyang
2022-12-07
Active, closed
China Rural Hypertension Control Project
NCT03527719Hypertension
First Hospital of China Medical University
Not applicable
33,995
Shenyang
2018-05-08
Recruiting
A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China
NCT07040306Gravesยด Disease
First Hospital of China Medical University
Observational
1,000
Shenyang
2012-11-14
Rows per page Showing 1–21 of 21
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/shenyang

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 21 of those studies with a site in Shenyang that also match the filters currently applied.

How many clinical trials are recruiting in Shenyang?

15 of the 21 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 4 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shenyang), 21 studies
PhaseStudiesRecruitingShare
Not applicable10747.6%
Observational8638.1%
Phase 1/2104.8%
Phase 2114.8%
Phase 4114.8%

Most active sponsors

Lead sponsors with the most studies (Shenyang)
Lead sponsorStudiesRecruiting
First Hospital of China Medical University2115
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.